Company / Revenue per Share
LENZ Therapeutics, Inc. Revenue per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.69
FY2025
5-year range
$0.69 / $0.69
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#112 of 154
Health Care
What the data says
At $0.69, LENZ Therapeutics, Inc.'s revenue per share ranks #112 of 154 in the Health Care sector.
Based on SEC 10-K filings.
0.69 in FY2025.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 154 in Health CareTop 73% of 154This company $0.69 Sector average $15.09
▼
-95.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026